Answers are grounded in this paper and cite their sources.
Several methods exist for testing the bioequivalence in bioavailability trials. In this article we propose a method for testing the equivalence of two drugs in clinical trials when the response variable is assumed to have a normal distribution. The null and alternative hypotheses are formulated in a nonconventional manner. Computing aspects for the power and sample size are discussed.
No takes yet. Share an insight, caveat, or question.
Patel et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: